Bajaj Healthcare Limited will conduct its earnings call to discuss financial performance for the second quarter and first half of fiscal year 2027 on Monday, October 19, 2026. The session is scheduled for 5:00 pm IST.

The company announced the schedule in a filing dated October 14, 2026, referencing its earlier intimation from October 9, 2026. This communication serves as an update under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Management participation

The earnings call will be led by senior management members to address investor queries regarding the results for the period ended September 30, 2026.

Access details

Investors and analysts can participate in the call via universal dial-in numbers or international toll-free lines. Pre-registration is recommended to minimize wait times.

Dial-in numbers

• Universal: +91 22 6280 1550 / +91 22 7115 8378
• Hong Kong: 800964448
• Singapore: 8001012045
• UK: 08081011573
• USA: 18667462133

Participants may pre-register through the Diamond Pass link provided by the company. For further inquiries, stakeholders can contact Rohan Parekh at investors@bajajhealth.com or Prachi Ambre at MUFG Intime India Private Limited.

Bajaj Healthcare declared a final dividend of ₹1.50 per equity share for FY26 at its 33rd Annual General Meeting held on September 21, 2026, with all six resolutions receiving the requisite majority. The company subsequently submitted voting results and a consolidated scrutinizer's report to stock exchanges on September 22, 2026.

The AGM was conducted via video conferencing from 3:00 pm to 3:34 pm. A total of 49 members attended through video conferencing, comprising 7 from the promoter and promoter group and 42 from the public. The record date for voting eligibility was September 14, 2026, on which the total number of shareholders stood at 41,967. Remote e-voting was open from September 17, 2026 at 9:00 am to September 20, 2026 at 5:00 pm, with e-voting also provided to shareholders present at the AGM.

Key resolutions approved

Shareholders transacted the following items of business:

• Adoption of audited financial statements for the year ended March 31, 2026
• Declaration of final dividend of ₹1.50 per equity share for FY26
• Reappointment of Whole-Time Director Pakshal Anil Jain, who retired by rotation
• Continuation of Independent Director Gopalakrishnan Kesavan's tenure upon attaining age 75
• Approval of remuneration for Non-Executive Non-Independent Director Sandeep Shah for FY27
• Ratification of Cost Auditor remuneration for FY27

Voting results summary

All six resolutions were passed. The table below presents the consolidated voting outcome across resolutions, reflecting votes polled as a percentage of total outstanding shares of 33,665,161.

Resolution 3, concerning the reappointment of Pakshal Anil Jain as director, drew the highest dissent, with 568,932 votes against, representing 2.7902% of votes polled. All other resolutions recorded dissent of 11 votes or 14 votes, amounting to 0.0001% of votes polled.

Scrutinizer and governance details

Haresh Sanghvi, Practicing Company Secretary (FCS 2259, CoP No. 3675), was appointed as Scrutinizer by the Board of Directors on July 20, 2026, and issued his consolidated report on September 21, 2026. Voting was conducted through the e-voting platform of National Securities Depository Limited. The scrutinizer's report was countersigned by an authorised signatory for Bajaj Healthcare Limited on September 22, 2026.

The Statutory Auditors' Report and Secretarial Audit Report for FY26 were taken as read during the meeting, with no qualifications or observations noted. The consolidated e-voting results were submitted to stock exchanges within two working days, in compliance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.